Physician profile
Pardeep Kumar
NPI 1528290772
$2,270.80
in general payments reported to CMS, 2019-2025
15 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $55.86 · 2021: $74.05 · 2022: $371 · 2023: $284 · 2024: $484 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $926.97 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $269.98 | 2019-2025 | |
| Abbvie INC. | $254.30 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $136.77 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $116.71 | 2019-2024 | Eliquis |
| Pfizer INC. | $99.38 | 2019-2025 | |
| Novo Nordisk INC | $93.31 | 2022-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $85.63 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.44 | 2019-2022 | |
| Cvrx, INC. | $52.38 | 2024 | Barostim Neo System |
| Silk Road Medical, INC. | $45.13 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbott Laboratories | $43.24 | 2022-2025 | Cardiomems |
| Boston Scientific Corporation | $32.42 | 2025 | Watchman Access System |
| Melinta Therapeutics, LLC | $28.76 | 2019 | |
| Bard Peripheral Vascular, INC. | $20.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pardeep Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.